Shifting from clinical to molecular-based diagnosis of Cornelia de Lange Syndrome: 11 novel variants with a lack of limb deformities

Abstract Objectives Cornelia de Lange syndrome (CdLS) is a rare developmental disorder with marked genetic and phenotypic variability. We characterized a national cohort of 24 individuals with suspected CdLS, with an emphasis on prenatal findings, genetic diagnoses, and population-specific features. Methods We performed a retrospective cohort study using medical records, prenatal imaging and screening data, growth parameters, congenital anomalies, neurodevelopmental outcomes, and caregiver interviews to assess behavioral characteristics. Results CdLS was confirmed in 20 individuals, and pathogenic or likely pathogenic variants were identified in 19. NIPBL was most frequently affected, followed by SMC1A , SMC3 , and HDAC8 ; no RAD21 or MAU2 -associated cases were identified. Eleven variants were previously unreported, and mosaicism was detected in 15% of cases. Routine prenatal testing, including ultrasound surveillance funded through national health insurance, detected fetal growth restriction and suspicious findings, yet no fetus was suspected prenatally as having CdLS. Postnatally, all individuals had global developmental delays, and behavioral difficulties represented the greatest caregiver burden. Notably, limb reduction anomalies, commonly reported in CdLS cohorts, were rare in this cohort. Conclusions This national cohort identifies novel genetic and clinical features of CdLS and highlights limitations of current prenatal detection. Earlier genomic testing and refined clinical criteria may improve timely diagnosis. Impact Prenatal Gaps: Routine ultrasounds flagged fetal growth restriction, but Cornelia de Lange syndrome (CdLS) was never suspected before birth. Genetic Discoveries: Identified 11 new genetic variants and revealed mosaicism (different genetic makeups in different cells) in 15% of cases. Broader Spectrum: A lower rate of limb anomalies suggests traditional clinical definitions may miss milder or atypical molecular cases. Caregiver Impact: Behavioral and communication challenges drive heavy caregiver burden, underscoring the urgent need for early diagnosis and lifelong support. First Israeli Cohort: Provides the country’s first comprehensive clinical, prenatal, genetic, and behavioral profiling of CdLS.

Authors

Institutions

Publication Details

Journal
Pediatric Research
Published
2026-11-17
DOI
https://doi.org/10.1038/s41390-026-05646-5
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Shifting from clinical to molecular-based diagnosis of Cornelia de Lange Syndrome: 11 novel variants with a lack of limb deformities

Tzipora C. Falik‐Zaccai, Itay Onn, Saray Ben-Artzi
Pediatric Research
Genomics and Rare Diseases
article

Shifting from clinical to molecular-based diagnosis of Cornelia de Lange Syndrome: 11 novel variants with a lack of limb deformities

Tzipora C. Falik‐Zaccai, Itay Onn, Saray Ben-Artzi
article en

Abstract

Abstract Objectives Cornelia de Lange syndrome (CdLS) is a rare developmental disorder with marked genetic and phenotypic variability. We characterized a national cohort of 24 individuals with suspected CdLS, with an emphasis on prenatal findings, genetic diagnoses, and population-specific features. Methods We performed a retrospective cohort study using medical records, prenatal imaging and screening data, growth parameters, congenital anomalies, neurodevelopmental outcomes, and caregiver interviews to assess behavioral characteristics. Results CdLS was confirmed in 20 individuals, and pathogenic or likely pathogenic variants were identified in 19. NIPBL was most frequently affected, followed by SMC1A , SMC3 , and HDAC8 ; no RAD21 or MAU2 -associated cases were identified. Eleven variants were previously unreported, and mosaicism was detected in 15% of cases. Routine prenatal testing, including ultrasound surveillance funded through national health insurance, detected fetal growth restriction and suspicious findings, yet no fetus was suspected prenatally as having CdLS. Postnatally, all individuals had global developmental delays, and behavioral difficulties represented the greatest caregiver burden. Notably, limb reduction anomalies, commonly reported in CdLS cohorts, were rare in this cohort. Conclusions This national cohort identifies novel genetic and clinical features of CdLS and highlights limitations of current prenatal detection. Earlier genomic testing and refined clinical criteria may improve timely diagnosis. Impact Prenatal Gaps: Routine ultrasounds flagged fetal growth restriction, but Cornelia de Lange syndrome (CdLS) was never suspected before birth. Genetic Discoveries: Identified 11 new genetic variants and revealed mosaicism (different genetic makeups in different cells) in 15% of cases. Broader Spectrum: A lower rate of limb anomalies suggests traditional clinical definitions may miss milder or atypical molecular cases. Caregiver Impact: Behavioral and communication challenges drive heavy caregiver burden, underscoring the urgent need for early diagnosis and lifelong support. First Israeli Cohort: Provides the country’s first comprehensive clinical, prenatal, genetic, and behavioral profiling of CdLS.

Pediatric Research
Bar-Ilan University (IL)
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon